Meyer D. Glantz, PhD, is the associate director for science and acting deputy director of the Division of Epidemiology and Prevention Research of the National Institute on Drug Abuse (NIDA), National Institutes of Health. At NIDA, Dr. Glantz has previously served as the chief of the Epidemiology Research Branch and the director of the Etiology Research Program. Prior to coming to NIDA he worked as a researcher and clinician at the Veterans Administration Clinic in Boston.
Dr. Glantz is a Fellow of the American Psychological Association and serves as a consultant to and board member of a variety of scientific and professional organizations and publications. He is the author of numerous articles and chapters on substance abuse, drug abuse etiology, cognitive therapy, and the elderly and has edited several volumes including Vulnerability to Drug Abuse, Biobehavioral Research Approaches to Drug Abuse Etiology, and Resilience and Development: Positive Life Adaptations. In addition, he maintains a private clinical practice in the Washington, DC area, supervises other clinicians, and is a lecturer for the Montgomery County Adult Education program. Dr. Glantz received his doctorate from Harvard University in 1979.
Christine R. Hartel, PhD, is associate executive director for science at the American Psychological Association, where she represents the scientific and science policy interests of the association to federal and state agencies, other scientific and professional organizations, and APA governance groups. She was elected a Fellow of the Association this year. Dr. Hartel worked for six years at the National Institute on Drug Abuse, awarding grants and contracts for basic and clinical research on drug abuse in the fields of neuroscience, behavior, pharmacology, and chemistry. She has written many articles, technical reports, and book chapters on drugs and the brain, amphetamine research, and the medical uses of marijuana. She also edited the book Biomedical Approaches to Illicit Drug Demand Reduction.
Dr. Hartel has been a consultant to the World Health Organization on the effects of marijuana. As a research psychologist at the U.S. Army Research Institute for the Behavioral and Social Sciences, she studied the cognitive effects of drugs and other stressors on soldier performance, as well as their implications for the design of weapons systems. In 1985, Dr. Hartel received the Army's Research and Development Award, the highest civilian honor conferred by the Army for technical excellence. Dr. Hartel received her PhD in biopsychology from the University of Chicago in 1985.
;){kind=link}